Skip to content

Brought to you by

Dentons logo

Canada Regulatory Review

The latest information and developments on regulatory law across Canada.

open menu close menu

Canada Regulatory Review

  • Home
  • About Us
  • Dentons COVID-19 hub

#Eatclean #HeartHealth #Getyourstepsin! Will your health and fitness app be regulated as a medical device in Canada?

By Monica Song and Yulia Konarski
September 23, 2022
  • Health
  • Public Policy and Regulation
  • Regulatory
Share on Facebook Share on Twitter Share via email Share on LinkedIn

More and more consumers are using devices as an integral part of their personal health and fitness regimes. In response, businesses are developing and marketing an array of innovative software applications represented for a variety of health-related uses, from monitoring heart rate and tracking step count to calorie counters, nutrition advice and online fitness classes.

As the range of service offerings is continually expanding to address management and prevention of prevalent conditions, including obesity, abnormal cardiac activity, gut health, etc., so is the risk that an application is considered a “medical device” within the meaning of the Medical Devices Regulations. 

It is critical that businesses ask the question “will my application, as proposed, be regulated as a medical device?” before marketing the app.

The definition of a “medical device” is quite broad and includes anything that is manufactured, sold or represented for use in “diagnosing, treating, mitigating or preventing a disease, disorder or abnormal physical state, or any of their symptoms in human beings,” and also in “restoring, modifying or correcting the body structure of human beings or the functioning of any part of the bodies of human beings.” Arguably, under a broad interpretation, a recommended daily step count / tracker may be considered as represented for use in preventing obesity and as such, may be considered a “medical device.”

In practice, Health Canada does not enforce the legislation (Food and Drugs Act) against certain products.  In particular, Health Canada has indicated that software applications that meet exclusion criteria detailed in Health Canada guidance on the topic are excluded from regulation as a medical device, notwithstanding that the software may be captured by the legal definition of a “medical device.” The policy rationale behind this administrative stance is based on the view that software apps intended to support or encourage a healthy lifestyle should not be regulated as medical devices.  Subject to a case-by-case assessment of the functions, features and claims associated with wellness apps, a case for their exclusion could be made. 

Excluding software applications that pose a low risk of potential harm to human health and safety from being regulated as medical devices would also align with Health Canada’s broader compliance and enforcement policy, which prioritizes strict compliance of health products, including medical devices, that pose a higher risk of potential harm to the health and safety of consumers. 

It remains critically important to undertake a case-by-case assessment under applicable laws and regulations before marketing new wellness app products or features. 

For questions regarding classification as a medical device or risk mitigation strategies in marketing and advertising of new health and fitness applications, please contact Monica Song (monica.song@dentons.com ) and Yulia Konarski (yulia.konarski@dentons.com).

Share on Facebook Share on Twitter Share via email Share on LinkedIn
Subscribe and stay updated
Receive our latest blog posts by email.
Stay in Touch
Monica Song

About Monica Song

Monica Song leads the Communications Law group of Dentons Canada LLP. A skilled administrative lawyer with in-depth knowledge of the business, legal, regulatory, licensing, and public policy issues affecting the communications industry, she has over 20 years’ experience advising clients in the sector, including wireline and wireless carriers, resellers, satellite operators, cable companies, Internet service providers, cloud-based application service providers, digital media undertakings, content providers, and equipment manufacturers and distributors. She also oversees the provision of tailored commercial, access to information, lawful access, lobbying, privacy, marketing and advertising, copyright and transactional advisory services to clients in the sector.

All posts Full bio

Yulia Konarski

About Yulia Konarski

Yulia Konarski is an associate in our Regulatory group with a practice that focuses on regulated products under the Food and Drugs Act, including food, drugs, natural health products, cosmetics and medical devices. Yulia regularly advises clients about their obligations in relation to importing and selling these products into Canada.

All posts Full bio

RELATED POSTS

  • ESG
  • Modern Slavery
  • Public Policy and Regulation
  • Regulatory

Canada’s modern slavery framework: New reporting obligations

By Paul Lalonde, Yasmin Shaker, Sean Stephenson, and Daniela Acevedo | November 16, 2022
  • International Trade
  • Public Policy and Regulation
  • Regulatory
  • Trade, WTO and Customs

United States re-imposes aluminum tariffs on certain Canadian aluminum products

By Paul Lalonde and Sean Stephenson | August 14, 2020
  • COVID-19
  • Public Procurement
  • Regulatory

Government procurement and COVID-19: Essential developments and key points for contractors and suppliers

By Paul Lalonde and Sean Stephenson | March 27, 2020

About Dentons

Dentons is designed to be different. As the world’s largest law firm with 20,000 professionals in over 200 locations in more than 80 countries, we can help you grow, protect, operate and finance your business. Our polycentric and purpose-driven approach, together with our commitment to inclusion, diversity, equity and ESG, ensures we challenge the status quo to stay focused on what matters most to you. www.dentons.com

Dentons boilerplate image

Twitter

Categories

  • Aboriginal
  • Administrative Law
  • Anti-Corruption
  • Anti-Money Laundering
  • Aviation
  • Broadcasting
  • Cannabis
  • Class Action Defense
  • Climate Change
  • Climate Change
  • Commercial Litigation
  • Communications
  • Competition
  • Consumer Products
  • COVID-19
  • Data
  • Drones
  • Energy
  • Environmental
  • ESG
  • Event
  • Expropriation
  • Financial
  • FinTech
  • Foreign Investment Review
  • Franchising and Distribution
  • Global Mobility
  • Government Affairs
  • Government Investigations
  • Health
  • Immigration
  • International Trade
  • Judicial Review
  • Litigation and Dispute Resolution
  • Marketing/Advertising
  • Mergers & Acquisitions
  • Mining
  • Modern Slavery
  • Municipal
  • National Security
  • Privacy
  • Privacy and Cybersecurity
  • Product regulation
  • Professional Liability
  • Public Policy and Regulation
  • Public Procurement
  • Real Estate
  • Regulatory
  • Russia
  • Sanctions
  • Securities
  • Smart Cities
  • Supply chain
  • Tax
  • Technology
  • Technology, Media and Communications
  • Trade and Economic Sanctions
  • Trade, WTO and Customs
  • Transportation
  • Ukraine/Russia
  • White Collar Crime
Dentons logo

© 2023 Dentons

  • Legal notices
  • Privacy policy
  • Terms of use
  • Cookies on this site